Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 as the current version, replacing the previous v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T03:03:17.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label changed from v3.5.2 to v3.5.3, indicating a newer version of the page. This change is a metadata update rather than a modification to study data or content.
    Difference
    0.1%
    Check dated 2026-04-30T17:25:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.5.0 to Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:07.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added 'Carcinoma of esophagus' to the conditions listed for the study.
    Difference
    0.1%
    Check dated 2026-04-02T00:14:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:24:27.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:55:06.000Z thumbnail image

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.